SCHEMBL7985536

SCHEMBL7985536

CCc1nc(O)c2c(ncn2CCCOc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 2/20 0.42
ALOX15 P16050 1/20 0.42
TP53 P04637 3/20 0.41
HTT P42858 3/20 0.41
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
CNOT7 Q9UIV1 1/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
MCL1 Q07820 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985772 0.94 L3MBTL1 (0.45) SMN1; SMN2LMNATSHRALOX15HTT
SCHEMBL7985446 0.77 GBA1 (0.41) SMN1; SMN2LMNATSHRALOX15TP53
SCHEMBL7973934 0.75 CYP11B1 (0.45) SMN1; SMN2ALDH1A1KMT2A
SCHEMBL7985534 0.74 L3MBTL1 (0.44) SMN1; SMN2LMNATSHRALOX15TP53
SCHEMBL7985082 0.74 HTT (0.46) LMNATSHRHTTMAPTCNOT7
SCHEMBL7985651 0.74 CYP1A2 (0.41) SMN1; SMN2ALDH1A1KMT2A
SCHEMBL7988883 0.73 CYP11B1 (0.46) SMN1; SMN2LMNATSHRTP53MAPT
SCHEMBL7984944 0.72 CNOT7 (0.44) LMNATSHRL3MBTL1CNOT7ALDH1A1
SCHEMBL7988251 0.72 NR1H3 (0.43) SMN1; SMN2TSHRCNOT7ALDH1A1NPC1
SCHEMBL7984482 0.71 GBA1 (0.42) SMN1; SMN2LMNATSHRALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed